The politics of innovation: Ideomed CEO offers perspective on mobile health regulation
The shift in the U.S. Food and Drug Administration’s approach to regulating some mobile health applications is benefiting companies such as Ideomed. The 4-year old company’s app Abriiz helps users track chronic conditions, such as asthma and diabetes, by integrating data from mobile health devices. Abriiz is also considered a medical device data system, an […]